Protective effects of ebselen (Ebs) and para-aminosalicylic acid (PAS) against manganese (Mn)-induced neurotoxicity.

[1]  S. Zeng,et al.  Brain Regional Pharmacokinetics of p-Aminosalicylic Acid and Its N-Acetylated Metabolite: Effectiveness in Chelating Brain Manganese , 2011, Drug Metabolism and Disposition.

[2]  W. Hanneman,et al.  Manganese-induced NF-kappaB activation and nitrosative stress is decreased by estrogen in juvenile mice. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  V. Felipo,et al.  p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts , 2011, Gut.

[4]  M. Aschner,et al.  Prolactin is a peripheral marker of manganese neurotoxicity , 2011, Brain Research.

[5]  S. Basu.  Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  K. Kristiansen,et al.  beta-oxidation modulates metabolic competition between eicosapentaenoic acid and arachidonic acid regulating prostaglandin E(2) synthesis in rat hepatocytes-Kupffer cells. , 2010, Biochimica et biophysica acta.

[7]  A. Ghio,et al.  Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes , 2010, Archives of Toxicology.

[8]  E. Catapane,et al.  Effects of p-Aminosalicylic acid on the neurotoxicity of manganese on the dopaminergic innervation of the cilia of the lateral cells of the gill of the bivalve mollusc, Crassostrea virginica. , 2010, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[9]  M. Aschner,et al.  Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. , 2009, Toxicology and applied pharmacology.

[10]  E. Puscheck,et al.  Multiple metals predict prolactin and thyrotropin (TSH) levels in men. , 2009, Environmental research.

[11]  J. Morrow,et al.  Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. , 2009, Free radical biology & medicine.

[12]  B. Fiebich,et al.  Resveratrol inhibits prostaglandin formation in IL-1β-stimulated SK-N-SH neuronal cells , 2009, Journal of Neuroinflammation.

[13]  Chontita Rattanakul,et al.  A mathematical model of prolactin secretion: Effects of dopamine and thyrotropin-releasing hormone , 2009, Math. Comput. Model..

[14]  Xueqian Wang,et al.  Chelation therapy of manganese intoxication with para-aminosalicylic acid (PAS) in Sprague-Dawley rats. , 2009, Neurotoxicology.

[15]  M. Aschner,et al.  Measurement of Isoprostanes as Markers of Oxidative Stress in Neuronal Tissue , 2009, Current protocols in toxicology.

[16]  M. Aschner,et al.  Antioxidants prevent the cytotoxicity of manganese in RBE4 cells , 2008, Brain Research.

[17]  A. Santamaria,et al.  Manganese exposure, essentiality & toxicity. , 2008, The Indian journal of medical research.

[18]  Gary W Miller,et al.  The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. , 2008, Biochemical pharmacology.

[19]  P. Chardon,et al.  Quantification of urinary F2-isoprostanes with 4(RS)-F4t-neuroprostane as an internal standard using gas chromatography-mass spectrometry Application to polytraumatized patients. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Jau-Shyong Hong,et al.  Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. , 2008, Trends in immunology.

[21]  T. Montine,et al.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease. , 2008, Current medicinal chemistry.

[22]  M. Aschner,et al.  Manganese transport in eukaryotes: the role of DMT1. , 2008, Neurotoxicology.

[23]  M. Aschner,et al.  Mitochondrial-dependent manganese neurotoxicity in rat primary astrocyte cultures , 2008, Brain Research.

[24]  B. Crain,et al.  Elevated microsomal prostaglandin-E synthase–1 in Alzheimer’s disease , 2008, Alzheimer's & Dementia.

[25]  A. Kurunczi,et al.  Behavioral effects of subchronic inorganic manganese exposure in rats. , 2007, American journal of industrial medicine.

[26]  R. Roesler,et al.  Pharmacology and toxicology of diphenyl diselenide in several biological models. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[27]  M. Aschner,et al.  Modulation of cholinergic systems by manganese. , 2007, Neurotoxicology.

[28]  M. Aschner,et al.  Manganese induces oxidative impairment in cultured rat astrocytes. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  Y. Ou,et al.  Induction of cyclooxygenase-2 expression by manganese in cultured astrocytes , 2007, Neurochemistry International.

[30]  K. P. Bhabak,et al.  Synthesis, characterization, and antioxidant activity of some ebselen analogues. , 2007, Chemistry.

[31]  H. Cheong,et al.  Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings. , 2007, Neurotoxicology.

[32]  T. A. Najjar,et al.  Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats. , 2006, Basic & clinical pharmacology & toxicology.

[33]  J. Lai,et al.  Manganese-Induced Neurotoxicity is Differentially Enhanced by Glutathione Depletion in Astrocytoma and Neuroblastoma Cells , 2006, Neurochemical Research.

[34]  M. Wessling-Resnick,et al.  Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. , 2006, Chemistry & biology.

[35]  Harvey J Clewell,et al.  Application of pharmacokinetic data to the risk assessment of inhaled manganese. , 2006, Neurotoxicology.

[36]  M. Aschner,et al.  The Manganese Health Research Program (MHRP): status report and future research needs and directions. , 2006, Neurotoxicology.

[37]  Stephen B. Miller.  Prostaglandins in health and disease: an overview. , 2006, Seminars in arthritis and rheumatism.

[38]  M. Aschner.  Manganese as a Potential Confounder of Serum Prolactin , 2006, Environmental health perspectives.

[39]  Sanae Nakagawa,et al.  Manganese exposure: neuropsychological and neurological symptoms and effects in welders. , 2006, Neurotoxicology.

[40]  Jean Lambert,et al.  Bioaccumulation and locomotor effects of manganese sulfate in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. , 2006, Toxicology and applied pharmacology.

[41]  T. Montine,et al.  Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by α- or γ-tocopherol , 2005 .

[42]  N. Kaplowitz,et al.  Hepatic mitochondrial glutathione: transport and role in disease and toxicity. , 2005, Toxicology and applied pharmacology.

[43]  N. Bazan,et al.  Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. , 2005, Journal of neurophysiology.

[44]  M. Aschner,et al.  Manganese exposure and induced oxidative stress in the rat brain. , 2004, The Science of the total environment.

[45]  T. Satoh,et al.  Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps , 2004, Neuroscience Letters.

[46]  D Mergler,et al.  Blood manganese content at birth and cord serum prolactin levels. , 2004, Neurotoxicology and teratology.

[47]  Wei Zheng,et al.  Manganese toxicity upon overexposure , 2004, NMR in biomedicine.

[48]  Shigeo Kobayashi,et al.  Signaling the brain in inflammation: the role of endothelial cells. , 2004, Frontiers in bioscience : a journal and virtual library.

[49]  F. J. Romero,et al.  Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia. , 2004, European journal of pharmacology.

[50]  M. Aschner,et al.  Airborne manganese exposure differentially affects end points of oxidative stress in an age-and sex-dependent manner , 2004, Biological Trace Element Research.

[51]  Michael Aschner,et al.  Manganese-induced cytotoxicity in dopamine-producing cells. , 2004, Neurotoxicology.

[52]  W. Cacheux,et al.  Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis. , 2004, Inflammatory bowel diseases.

[53]  T. Montine,et al.  Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. , 2004, Chemistry and physics of lipids.

[54]  Surong Zhang,et al.  In vitro effect of manganese chloride exposure on reactive oxygen species generation and respiratory chain complexes activities of mitochondria isolated from rat brain. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[55]  Eric J. Esswein,et al.  The utility of biological monitoring for manganese in ferroalloy smelter workers in South Africa. , 2003, Neurotoxicology.

[56]  N. Keim,et al.  Dietary selenium intake modulates thyroid hormone and energy metabolism in men. , 2003, The Journal of nutrition.

[57]  P. Schulz,et al.  Parkinsonism due to Manganism in a Welder , 2003, International journal of toxicology.

[58]  J. Morrow,et al.  Age-independent, gray matter-localized, brain-enhanced oxidative stress in male fischer 344 rats: brain levels of F(2)-isoprostanes and F(4)-neuroprostanes. , 2003, Free radical biology & medicine.

[59]  Y. Thomassen,et al.  Endocrine and immunologic markers in manganese alloy production workers. , 2003, Scandinavian journal of work, environment & health.

[60]  N. Matsumoto,et al.  Ebselen protects against the reduction in levels of drug-metabolizing enzymes in livers of rats with deoxycholic acid-induced liver injury. , 2002, Pharmacology & toxicology.

[61]  A. Holmgren,et al.  Ebselen: A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  E. Niki,et al.  Ebselen, a Glutathione Peroxidase Mimetic Seleno-organic Compound, as a Multifunctional Antioxidant , 2002, The Journal of Biological Chemistry.

[63]  E. Aizenman,et al.  The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site , 2001, Journal of neurochemistry.

[64]  G. FitzGerald,et al.  The isoprostanes in biology and medicine , 2001, Trends in Endocrinology & Metabolism.

[65]  E. Malecki.  Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons , 2001, Brain Research Bulletin.

[66]  J. Yoshino,et al.  Preventive effect of ebselen on acute gastric mucosal lesion development in rats treated with compound 48/80. , 2001, European journal of pharmacology.

[67]  R. Dringen,et al.  Metabolism and functions of glutathione in brain , 2000, Progress in Neurobiology.

[68]  M. Liu,et al.  Manganese administration induces the increased production of dopamine sulfate and depletion of dopamine in Sprague-Dawley rats. , 2000, Journal of biochemistry.

[69]  Shimada,et al.  Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. , 2000, The Tohoku journal of experimental medicine.

[70]  T. Uliasz,et al.  Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. , 2000, The Journal of pharmacology and experimental therapeutics.

[71]  D. Placidi,et al.  Mechanism of neurobehavioral alteration. , 2000, Toxicology letters.

[72]  M. Parnham,et al.  Ebselen: prospective therapy for cerebral ischaemia , 2000, Expert opinion on investigational drugs.

[73]  J. Morrow,et al.  Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. , 2000, Free radical biology & medicine.

[74]  O. Griffith,et al.  Biologic and pharmacologic regulation of mammalian glutathione synthesis. , 1999, Free radical biology & medicine.

[75]  S. Y. Yang,et al.  Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury. , 1999, Surgical neurology.

[76]  Shelly C. Lu.  Regulation of hepatic glutathione synthesis: current concepts and controversies , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  D. Graham,et al.  Neuroprotective efficacy of ebselen, an anti‐oxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion , 1997, British journal of pharmacology.

[78]  G. Esposito,et al.  Glutathione deficiency potentiates manganese toxicity in rat striatum and brainstem and in PC12 cells. , 1997, Pharmacological research.

[79]  M. Sato,et al.  Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain , 1997, Neuroradiology.

[80]  K. Seibert,et al.  Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo , 1996, The Journal of experimental medicine.

[81]  C. Pinson,et al.  Plasma prostaglandin E1 concentrations and hemodynamics during intravenous infusions of prostaglandin E1 in humans and swine. , 1996, Transplantation.

[82]  P. Isakson,et al.  Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. , 1996, The Journal of clinical investigation.

[83]  P. Worley,et al.  COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[84]  G. Esposito,et al.  Cellular defence mechanisms in the striatum of young and aged rats subchronically exposed to manganese , 1995, Neuropharmacology.

[85]  O. Ladefoged,et al.  Acetone potentiation and influence on the reversibility of 2,5-hexanedione-induced neurotoxicity studied with behavioural and morphometric methods in rats. , 1994, Pharmacology & toxicology.

[86]  Carol A. Barnes,et al.  Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids , 1993, Neuron.

[87]  A. Meister,et al.  Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[88]  R. C. Ewan.  Effect of selenium on rat growth, growth hormone and diet utilization. , 1976, The Journal of nutrition.

[89]  K. Kuriyama,et al.  Biochemical-physiology correlations in studies of the γ-aminobutyric acid system , 1968 .

[90]  R. Markoe.  The use of para-amino salicylic acid in the treatment of tuberculosis. , 1950, Journal of the National Medical Association.

[91]  J. Galano,et al.  Isoprostanes and phytoprostanes: Bioactive lipids. , 2011, Biochimie.

[92]  J. A. Saldivar-Gonzalez,et al.  Differential effect of clozapine and haloperidol on rats treated with methylphenidate in the open field test. , 2009, Proceedings of the Western Pharmacology Society.

[93]  Cano-Cruz Ma,et al.  Differential effect of clozapine and haloperidol on rats treated with methylphenidate in the open field test. , 2009 .

[94]  Hyonok Yoon,et al.  Protective effects of sodium para-amino salicylate on manganese-induced neuronal death: the involvement of reactive oxygen species. , 2009, The Journal of pharmacy and pharmacology.

[95]  M. L. Santos.  Study of biomarkers to evaluate the protective effects of antioxidants against manganese neurotoxicity , 2008 .

[96]  J. Morrow,et al.  Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. , 1999, Methods in enzymology.

[97]  K. Takakura,et al.  Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.

[98]  M. Fujiwara,et al.  Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test. , 1995, Japanese journal of pharmacology.